Encore Medical Starts U.S. IPO Process

Encore Medical aims to raise $17.25M in IPO funding for FDA heart device trials. Click here to read the latest analysis on ...
mccormick.northwestern.edu

Dissolving Cardiac Device Monitors, Treats Heart Disease

Nearly 700,000 people in the United States die from heart disease every year, and one-third of those deaths result from complications in the first weeks or months following a traumatic heart-related ...
TCTMD

TCT 1307: Puncture and Deployment of a Second Trans-ASD Closure Device: A Treatment Strategy for Displaced ASD Occluder in a High Surgical Risk Patient With Complex Anatomy

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...